 - To test the feasibility and safety of infusing anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells CD20Bi-AATC before stem cell mobilization and collection for autologous peripheral blood stem cell transplantation PBSCT in patients with multiple myeloma. 